Alnylam Pharmaceuticals (ALNY) Current Deferred Tax Assets (2009 - 2010)
Alnylam Pharmaceuticals posted quarterly Current Deferred Tax Assets of $1.9 million for Q3 2010, little changed on a QoQ basis from $1.9 million in Q2 2010.
Alnylam Pharmaceuticals (ALNY) has 2 years of Current Deferred Tax Assets data on file, last reported at $1.9 million in Q3 2010.
- For the quarter ending Q3 2010, Current Deferred Tax Assets changed N/A year-over-year to $1.9 million; the trailing twelve-month figure through Sep 2010 stood at $1.9 million (changed N/A YoY), and the FY2009 full-year result was $1.9 million, changed N/A from the prior year.
- Current Deferred Tax Assets for Q3 2010 stood at $1.9 million, roughly flat from $1.9 million in the prior quarter.
- Across five years, Current Deferred Tax Assets topped out at $1.9 million in Q3 2010 and bottomed at $1.9 million in Q4 2009.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2010 | 1.94 Mn |
| Sep 30, 2010 | 1.94 Mn |
| Jun 30, 2010 | 1.94 Mn |
| Jun 30, 2010 | 1.94 Mn |
| Dec 31, 2009 | 1.94 Mn |
| Dec 31, 2009 | 1.94 Mn |